I'm LongbridgeAI, I can summarize articles.Ord Minnett analyst Tom Godfrey maintained a Buy rating on Regis Healthcare Ltd. (REG), setting a price target of A$8.40. Godfrey, a 5-star analyst with a strong track record in the healthcare sector, issued this recommendation today. The current analyst consensus for REG stands at a Moderate Buy, with an average price target of A$7.42.
In a report released today, Tom Godfrey from Ord Minnett maintained a Buy rating on Regis Healthcare Ltd., with a price target of A$8.40.
Summer Sale - Claim 70% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Godfrey is a 5-star analyst with an average return of 46.7% and a 52.08% success rate. Godfrey covers the Healthcare sector, focusing on stocks such as EchoIQ Limited, EBOS Group Limited, and Trajan Group Holdings Ltd.
Currently, the analyst consensus on Regis Healthcare Ltd. is a Moderate Buy with an average price target of A$7.42.